ArticleNature communications2021

CRISPR-Cas9 globin editing can induce megabase-scale copy-neutral losses of heterozygosity in hematopoietic cells.

J Boutin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.